Trial Profile
Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)-A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Niacin (Primary) ; Simvastatin (Primary)
- Indications Atherosclerosis; Peripheral arterial disorders
- Focus Adverse reactions; Pharmacodynamics
- Acronyms NASCIT
- 02 Mar 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record .
- 02 Aug 2008 New trial record.